Sydney separation technology specialist Gradipore has revised upwards its projected loss for the financial year, from $AUD12 million to up to $16 million. [ + ]

Amrad and US monoclonal antibody company Medarex have signed a licensing partnership for the R&D of fully humanised monoclonal antibodies against Amrad's asthma target interleukin-13 receptor alpha. [ + ]

"Every high school student in Australia should have the opportunity to participate in the Science and Engineering Challenge," says Associate Professor John O'Connor, Head of the School of Mathematical and Physical Sciences in the Faculty of Science and Information Technology at the University of Newcastle.

US pharma Cephalon has increased its interest in delivery biotech Sirtex up to 41 per cent with the acquisition of just under 8,800,000 shares from founder Dr Bruce Gray. [ + ]

Australia's deepest pool of tropical marine scientists will receive $AUD5 million in fresh funding thanks to this week's federal budget. [ + ]

Melbourne University proteomic research has indicated a possible link between oral hygiene and heart disease. [ + ]

Recent events in the Australian manufacturing sector have raised the focus upon end-to-end quality assurance requirements and how the transparency of plant floor operations affects boardroom decision-making.

Listed biotech Agenix is ringing in changes to bolster its current blood diagnostics business while promoting the progress of its intended next-generation product, the Thromboview blood clot-imaging agent. [ + ]

The structure of a key energy-releasing enzyme found in all animals is designed to minimise free radical production, an international team of researchers has revealed.

A row is brewing between the Royal College of Pathologists Australasia and Genetic Technologies, the Melbourne-based biotechnology company that last year obtained an exclusive license to offer Myriad Genetics' BRCA1 and BRCA2 breast cancer susceptibility tests in Australia and New Zealand. [ + ]

Following intense activity around the globe, researchers have identified critical aspects of the SARS genome -- and now the race is on to file patents. [ + ]

UNSW engineering student David Snowdon is the NSW winner of the 2002/2003 Siemens Prize for Innovation, one of the country's richest awards offered within the tertiary engineering sector.

Researchers at The Burnham Institute in the US have found that humanin, a small, 24-amino acid protein recently discovered in studies of Alzheimer's Disease, suppresses activation of the protein Bax. Bax triggers pathologic cell death in a number of diseases, including Parkinson's, stroke, heart attack and degeneration of ovaries during menopause. These results suggest a novel target for therapeutic design based on inhibiting the cell destructive activity of Bax.

Australia's agribiotechnology industry has reluctantly accepted the Victorian government's decision to impose a 12-month voluntary moratorium on growing Australia's first commercial crops of genetically modified (GM) canola in Victoria. [ + ]

Perth entrepreneur Farooq Khan is maintaining a stiff upper lip in the aftermath of his failed bid for a board seat on Biota Holdings. [ + ]